DK2230253T3 - Antistoffer mod en homolog til MDR-P-glycoproteinet på kromosom 7p15-21 og anvendelser deraf - Google Patents

Antistoffer mod en homolog til MDR-P-glycoproteinet på kromosom 7p15-21 og anvendelser deraf

Info

Publication number
DK2230253T3
DK2230253T3 DK10151972.6T DK10151972T DK2230253T3 DK 2230253 T3 DK2230253 T3 DK 2230253T3 DK 10151972 T DK10151972 T DK 10151972T DK 2230253 T3 DK2230253 T3 DK 2230253T3
Authority
DK
Denmark
Prior art keywords
glycoprotein
multidrug resistance
mdr
chromosome
methods
Prior art date
Application number
DK10151972.6T
Other languages
English (en)
Inventor
Markus H Frank
Mohamed H Sayegh
Original Assignee
Brigham & Womens Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brigham & Womens Hospital filed Critical Brigham & Womens Hospital
Application granted granted Critical
Publication of DK2230253T3 publication Critical patent/DK2230253T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
DK10151972.6T 2000-06-05 2001-06-05 Antistoffer mod en homolog til MDR-P-glycoproteinet på kromosom 7p15-21 og anvendelser deraf DK2230253T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20891300P 2000-06-05 2000-06-05
EP09180026.8A EP2182005B1 (en) 2000-06-05 2001-06-05 A gene encoding a multidrug resistance human P-glycoprotein homologue on chromosome 7p15-21 and uses thereof

Publications (1)

Publication Number Publication Date
DK2230253T3 true DK2230253T3 (da) 2013-11-18

Family

ID=22776565

Family Applications (4)

Application Number Title Priority Date Filing Date
DK10151972.6T DK2230253T3 (da) 2000-06-05 2001-06-05 Antistoffer mod en homolog til MDR-P-glycoproteinet på kromosom 7p15-21 og anvendelser deraf
DK09180026.8T DK2182005T3 (da) 2000-06-05 2001-06-05 Gen, der koder for en multiresistent homolog til human P-glycoprotein på kromosom 7p15-21, og anvendelser deraf
DK10185365.3T DK2298799T3 (da) 2000-06-05 2001-06-05 Gen, som koder for en human multiresistens-P-glycoproteinhomolog på kromosom 7p15-21, og anvendelser deraf
DK01941884.7T DK1290028T3 (da) 2000-06-05 2001-06-05 Gen, der koder for en multidrug-resistens-human P-glycoprotein-homolog på kromosom 7p15-21, og anvendelser deraf

Family Applications After (3)

Application Number Title Priority Date Filing Date
DK09180026.8T DK2182005T3 (da) 2000-06-05 2001-06-05 Gen, der koder for en multiresistent homolog til human P-glycoprotein på kromosom 7p15-21, og anvendelser deraf
DK10185365.3T DK2298799T3 (da) 2000-06-05 2001-06-05 Gen, som koder for en human multiresistens-P-glycoproteinhomolog på kromosom 7p15-21, og anvendelser deraf
DK01941884.7T DK1290028T3 (da) 2000-06-05 2001-06-05 Gen, der koder for en multidrug-resistens-human P-glycoprotein-homolog på kromosom 7p15-21, og anvendelser deraf

Country Status (11)

Country Link
US (6) US6846883B2 (da)
EP (5) EP2182005B1 (da)
AT (1) ATE452909T1 (da)
CA (1) CA2411101C (da)
CY (2) CY1109941T1 (da)
DE (1) DE60140868D1 (da)
DK (4) DK2230253T3 (da)
ES (4) ES2540102T3 (da)
HK (2) HK1143823A1 (da)
PT (4) PT2182005E (da)
WO (1) WO2001094400A2 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2411101C (en) 2000-06-05 2018-01-16 Brigham And Women's Hospital, Inc. A gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof
WO2003025174A2 (en) * 2001-09-06 2003-03-27 Bayer Healthcare Ag Regulation of human mrp1-like protein
HUE059011T2 (hu) 2006-05-31 2022-09-28 Childrens Medical Center Immunmodulátorként szolgáló ABC5-pozitív mezenchimális õssejtek
SI2644205T1 (sl) 2007-04-12 2018-11-30 The Brigham And Women's Hospital, Inc. Ciljanje ABCB5 za zdravljenje raka
US11542328B2 (en) 2008-11-14 2023-01-03 The Brigham And Women's Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
US20110287034A1 (en) 2008-11-14 2011-11-24 The Brigham And Womens Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
CA2901931C (en) 2013-02-19 2023-03-07 Children's Medical Center Corporation Abcb5(+) stem cells for treating ocular disease
MX2015015536A (es) 2013-05-10 2016-08-08 Children's Medical Center Corp Cicatrización de heridas e ingenieria de tejido.
WO2018013993A1 (en) * 2016-07-14 2018-01-18 University Of Southern California Methods and composition for producing and using immune cells and stem cells for cell-based therapies
US20230203153A1 (en) * 2020-04-30 2023-06-29 Children's Medical Center Corporation Antibodies specific to abcb5 and uses thereof

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0174810B1 (en) * 1984-09-10 1993-07-21 HSC Research Development Corporation Multidrug resistance in mammalian cell lines and isolation of determinant glycoprotein dna
US4837306A (en) 1985-02-25 1989-06-06 The Ontario Cancer Institute Method for selecting hybridomas producing antibodies specific to the P-glycoprotein cell suface antigen and a cDNA clone encoding the C-terminal portion of the antigen
US5693622A (en) 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
US5399483A (en) 1989-03-30 1995-03-21 Suntory Limited Expression of MDR-related gene in yeast cell
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
US5434075A (en) * 1992-03-20 1995-07-18 Board Of Trustees Of The University Of Illinois Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses
IT1257893B (it) * 1992-06-17 1996-02-16 Ist Superiore Sanita Anticorpi monoclonali che riconoscono un epitopo della p-glicoproteina umana.
WO1994009363A1 (en) * 1992-10-14 1994-04-28 Board Of Regents, The University Of Texas System Cancer diagnosis and therapy
EP0882717B1 (en) 1996-10-01 2010-09-08 Kyowa Hakko Kirin Co., Ltd. Nitrogenous heterocyclic compounds
US6020191A (en) 1997-04-14 2000-02-01 Genzyme Corporation Adenoviral vectors capable of facilitating increased persistence of transgene expression
US6008002A (en) * 1997-09-29 1999-12-28 Bodey; Bela Immunomagnetic detection and isolation of cancer cells
DK1659178T3 (da) * 1998-02-05 2010-07-12 Glaxosmithkline Biolog Sa Fremgangsmåde til oprensning eller fremstilling af et MAGE-protein
ATE286118T1 (de) 1998-03-13 2005-01-15 Osiris Therapeutics Inc Anwendungen für humane nicht autologe, mesenchymale stammzellen
CA2384981A1 (en) * 1999-09-28 2001-04-05 Gentest Corporation P-glycoproteins and uses thereof
EP1290217A2 (en) * 2000-02-04 2003-03-12 Aeomica, Inc. Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence
CA2411101C (en) 2000-06-05 2018-01-16 Brigham And Women's Hospital, Inc. A gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof
KR100823764B1 (ko) 2000-06-22 2008-04-21 제넨테크, 인크. 아고니스트 안티-티알케이-씨 모노클로날 항체
EP1412387A2 (en) * 2000-10-27 2004-04-28 Incyte Genomics, Inc. Transporters and ion channels
US7829336B2 (en) * 2003-11-24 2010-11-09 The Rockefeller University Method for isolating a self-renewing, multipotent, slow-cycling cell
US20050186672A1 (en) 2004-01-27 2005-08-25 Reliance Life Sciences Pvt. Ltd. Tissue system with undifferentiated stem cells derived from corneal limbus
CA2629330C (en) 2004-11-12 2018-05-22 Cambridge University Technical Services Ltd. Methods and means related to cancer stem cells
WO2006103685A2 (en) 2005-03-28 2006-10-05 Vision Research Foundation A method for cultivating cells derived from corneal limbal tissue and cells deived from corneal limbal tissue
CA2612021A1 (en) 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
HUE059011T2 (hu) * 2006-05-31 2022-09-28 Childrens Medical Center Immunmodulátorként szolgáló ABC5-pozitív mezenchimális õssejtek
EP2526970A1 (en) * 2006-09-07 2012-11-28 Stemline Therapeutics, Inc. Monitoring cancer stem cells
SI2644205T1 (sl) 2007-04-12 2018-11-30 The Brigham And Women's Hospital, Inc. Ciljanje ABCB5 za zdravljenje raka
US20110287034A1 (en) 2008-11-14 2011-11-24 The Brigham And Womens Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
CA2901931C (en) 2013-02-19 2023-03-07 Children's Medical Center Corporation Abcb5(+) stem cells for treating ocular disease
MX2015015536A (es) 2013-05-10 2016-08-08 Children's Medical Center Corp Cicatrización de heridas e ingenieria de tejido.

Also Published As

Publication number Publication date
CA2411101A1 (en) 2001-12-13
WO2001094400A2 (en) 2001-12-13
EP3333182A1 (en) 2018-06-13
US20020037522A1 (en) 2002-03-28
WO2001094400A3 (en) 2002-07-04
HK1143823A1 (en) 2011-01-14
DK2182005T3 (da) 2015-06-29
PT1290028E (pt) 2010-03-12
EP2230253B1 (en) 2013-08-07
DK1290028T3 (da) 2010-04-26
ES2540102T3 (es) 2015-07-08
ES2659877T3 (es) 2018-03-19
HK1257165A1 (zh) 2019-10-18
EP2182005B1 (en) 2015-03-25
PT2298799T (pt) 2018-02-16
PT2182005E (pt) 2015-07-20
CA2411101C (en) 2018-01-16
US7465554B2 (en) 2008-12-16
EP2182005A1 (en) 2010-05-05
US6846883B2 (en) 2005-01-25
ATE452909T1 (de) 2010-01-15
PT2230253E (pt) 2013-11-11
EP1290028B1 (en) 2009-12-23
ES2338756T3 (es) 2010-05-12
ES2434721T3 (es) 2013-12-17
CY1121053T1 (el) 2019-12-11
DE60140868D1 (de) 2010-02-04
US20130287785A1 (en) 2013-10-31
US9561264B2 (en) 2017-02-07
DK2298799T3 (da) 2018-02-19
CY1109941T1 (el) 2014-09-10
EP1290028A2 (en) 2003-03-12
US20120034196A1 (en) 2012-02-09
EP2298799A1 (en) 2011-03-23
US20050049185A1 (en) 2005-03-03
EP2230253A1 (en) 2010-09-22
US20090162873A1 (en) 2009-06-25
US8076091B2 (en) 2011-12-13
EP2298799B1 (en) 2017-11-15
US8425876B2 (en) 2013-04-23
US20100145030A1 (en) 2010-06-10
US8507273B2 (en) 2013-08-13

Similar Documents

Publication Publication Date Title
HK1257165A1 (zh) 在染色體 7p15-21 上編碼多藥耐藥性人 p-糖蛋白同源染色體的基因及其用途
ATE353975T1 (de) Diagnose von mit apoptose assoziierten erkrankungen mittels ermittlung des methylierungszustandes von apoptose-assozierten genen
ATE364089T1 (de) Reagenzien und methoden zum nachweis von erkrankungen der brust
ATE353974T1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
WO2001096388A3 (en) Compositions and methods for the therapy and diagnosis of colon cancer
CY1105446T1 (el) Διαγνωση και θepαπεια διαταραχων που συνδεονται με aur1 και aur2
WO2001096390A3 (en) Compositions and methods for the therapy and diagnosis of colon cancer
DK1438340T3 (da) Antistoffer mod KDR, deres fremstilling og anvendelser
ATE476525T1 (de) Verfahren zum nachweis von mit endometrialer krankheit oder phase assoziierten markern
WO2001073027A3 (en) Compositions and methods for therapy and diagnosis of colon cancer
ATE463508T1 (de) Reagentien und verfahren zur erkennung von erkrankungen der brust
DK1536006T3 (da) Cancerantigener og anvendelse deraf
WO2001051513A3 (en) Ovarian tumor-associated sequences
WO2001057207A3 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
DK1095143T3 (da) Inhibitor til diagnosticering og behandling af patienter med hæmofili A
WO2001061055A3 (en) Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes
ATE449171T1 (de) Reagentia und verfahren zum nachweis von brustkrankheiten
WO2002070559A3 (en) Nuclear hormone receptor ligand binding domains
WO2001096389A3 (en) Compositions and methods for the therapy and diagnosis of colon cancer
WO2004074245A3 (en) Monkey alpha-7 nicotinic acetylcholine receptor and methods of use thereof
WO2002075317A3 (en) Screening for drugs against disorders associated with schizophrenia
WO2001065262A3 (en) Reagents and methods useful for detecting diseases of the breast
WO1999031274A3 (en) Reagents and methods useful for detecting diseases of the pancreas
WO2002012332A3 (en) Compositions and methods for the therapy and diagnosis of colon cancer
HUP0203080A2 (hu) A PRV-1 gén és felhasználása